Skip to content

Earnings yield at other companies

Avanos Medical logo
Avanos MedicalAVNS
-11.4%-5.1pp
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
7.1%+2.6pp
AtriCure logo
AtriCureATRC
-1.6%-0.5pp

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-16.0%
Enterprise value$1.21B+1.2%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Calculated from Pacira BioSciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s earnings yield?
Pacira BioSciences, Inc. (PCRX) reported earnings yield of 0.6% in Q1 2026.
What is the long-term trend for Pacira BioSciences, Inc.'s earnings yield?
Over 2 years (2020 to 2025), Pacira BioSciences, Inc.'s earnings yield has grown at a -66.0% compound annual growth rate (CAGR), from 5.5% to 0.6%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.